Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial.

Saoussen Ben Abdallah,Yosra Mhalla,Imen Trabelsi,Adel Sekma, Rim Youssef,Khaoula Bel Haj Ali,Houda Ben Soltane, Hajer Yacoubi,Mohamed Amine Msolli,Nejla Stambouli,Kaouthar Beltaief,Mohamed Habib Grissa, Meriem Khrouf,Zied Mezgar,Chawki Loussaief,Wahid Bouida,Rabie Razgallah, Karima Hezbri,Asma Belguith, Naouel Belkacem,Zohra Dridi,Hamdi Boubaker,Riadh Boukef,Semir Nouira

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America（2023）

引用 27|浏览7

暂无评分

摘要

Our results showed that, in COVID-19 patients, oral zinc can decrease 30-day death, ICU admission rate and can shorten symptom duration. Clinical Trials Registration. ClinicalTrials.gov, NCT05212480.

查看译文

关键词

COVID-19,SARS-CoV-2,outcome,zinc

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要